NMRD
Income statement / Annual
Last year (2023), Nemaura Medical Inc.'s total revenue was $77.04 K,
a decrease of 84.71% from the previous year.
In 2023, Nemaura Medical Inc.'s net income was -$14.14 M.
See Nemaura Medical Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
03/31/2023 |
03/31/2022 |
03/31/2021 |
03/31/2020 |
03/31/2019 |
03/31/2018 |
03/31/2017 |
03/31/2016 |
03/31/2015 |
03/31/2014 |
| Operating Revenue |
$77.04 K |
$503.91 K |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$1.55 M
|
$344.30 K
|
$98.08 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
-$1.48 M
|
$159.61 K
|
-$98.08 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
-19.16
|
0.32
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$1.54 M
|
$1.56 M
|
$1.55 M
|
$2.01 M
|
$2.30 M
|
$993.83 K
|
$1.03 M
|
$1.03 M
|
$824.50 K
|
$383.86 K
|
| General & Administrative Expenses |
$5.60 M
|
$6.17 M
|
$3.03 M
|
$2.77 M
|
$2.18 M
|
$915.13 K
|
$516.66 K
|
$511.41 K
|
$495.34 K
|
$202.38 K
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$5.60 M
|
$6.17 M
|
$3.03 M
|
$2.77 M
|
$2.18 M
|
$915.13 K
|
$516.66 K
|
$511.41 K
|
$495.34 K
|
$202.38 K
|
| Other Expenses |
$980.04 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$8.12 M
|
$7.73 M
|
$4.59 M
|
$4.78 M
|
$4.48 M
|
$1.91 M
|
$1.55 M
|
$1.54 M
|
$1.32 M
|
$586.23 K
|
| Cost And Expenses |
$9.67 M
|
$8.07 M
|
$4.59 M
|
$4.78 M
|
$4.48 M
|
$1.91 M
|
$1.55 M
|
$1.54 M
|
$1.32 M
|
$586.23 K
|
| Interest Income |
$0.00
|
$0.00
|
$2.01 M
|
$3.93 K
|
$23.93 K
|
$88.52 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$6.41 M
|
$6.67 M
|
$2.01 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$444.18 K
|
$229.81 K
|
$98.08 K
|
$54.84 K
|
$33.41 K
|
$29.26 K
|
$20.43 K
|
$17.40 K
|
$7.56 K
|
$5.10 K
|
| EBITDA |
-$7.29 M |
-$7.34 M |
-$4.49 M |
-$4.72 M |
-$4.44 M |
-$1.88 M |
-$1.53 M |
-$1.52 M |
-$1.31 M |
-$581.13 K |
| EBITDA Ratio |
-94.58
|
-14.57
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
-124.54
|
-15.02
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$4.55 M
|
-$6.67 M
|
-$2.01 M
|
$3.93 K
|
$23.93 K
|
$88.52 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Income Before Tax |
-$14.14 M
|
-$14.24 M
|
-$6.59 M
|
-$4.77 M
|
-$4.45 M
|
-$1.82 M
|
-$1.55 M
|
-$1.54 M
|
-$1.32 M
|
-$586.23 K
|
| Income Before Tax Ratio |
-183.58
|
-28.25
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
-$350.26 K
|
-$335.83 K
|
-$614.36 K
|
$23.93 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$14.14 M
|
-$13.89 M
|
-$6.26 M
|
-$4.16 M
|
-$4.45 M
|
-$1.82 M
|
-$1.55 M
|
-$1.54 M
|
-$1.32 M
|
-$586.23 K
|
| Net Income Ratio |
-183.58
|
-27.56
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-0.57 |
-0.59 |
-0.28 |
-0.2 |
-0.25 |
-0.0121 |
-0.0076 |
-0.0076 |
-0.0066 |
-0.0029 |
| EPS Diluted |
-0.57 |
-0.59 |
-0.28 |
-0.2 |
-0.25 |
-0.0121 |
-0.0076 |
-0.0076 |
-0.0066 |
-0.0029 |
| Weighted Average Shares Out |
$24.88 M
|
$23.38 M
|
$22.28 M
|
$20.81 M
|
$18.09 M
|
$150.07 M
|
$205.00 M
|
$201.73 M
|
$200.00 M
|
$200.00 M
|
| Weighted Average Shares Out Diluted |
$24.88 M
|
$23.38 M
|
$22.28 M
|
$20.81 M
|
$18.09 M
|
$150.07 M
|
$205.00 M
|
$201.73 M
|
$200.00 M
|
$200.00 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
